Insiders · Profile

Bernstein Harold

President, R&D & CMO at Maze Therapeutics. Filing since 29 Dec 2025. CIK 0002050172

Company
Date
Role
Action
Shares
Amount
Of holding
1 Oct 2026
President, R&D & CMO
Sold on a plan
16,141
$434.74K
100%
4 Sep 2026
President, R&D & CMO
Sold on a plan
9,705
$254.50K
100%
3 Sep 2026
President, R&D & CMO
Sold at will
5,189
$134.97K
34.8%
2 Sep 2026
President, R&D & CMO
Sold at will
5,106
$135.14K
25.5%
1 Sep 2026
President, R&D & CMO
Sold on a plan
16,141
$425.51K
100%
13 Aug 2026
President, R&D & CMO
Sold on a plan
16,142
$445.62K
100%
1 Jul 2026
President, R&D & CMO
Sold on a plan
14,609
$436.86K
100%
1 Jun 2026
President, R&D & CMO
Sold on a plan
14,853
$381.11K
100%
14 May 2026
President, R&D & CMO
Sold on a plan
15,000
$393.35K
100%
1 Apr 2026
President, R&D & CMO
Sold on a plan
15,000
$441.90K
100%
20 Mar 2026
President, R&D & CMO
Sold on a plan
15,000
$736.44K
100%
10 Mar 2026
President, R&D & CMO
Sold on a plan
30,000
$1.51M
100%
2 Feb 2026
President, R&D & CMO
Sold on a plan
15,000
$690.33K
100%
7 Jan 2026
President, R&D & CMO
Sold on a plan
25,156
$1.01M
100%
5 Jan 2026
President, R&D & CMO
Sold on a plan
412
$16.48K
100%
2 Jan 2026
President, R&D & CMO
Sold on a plan
4,432
$179.19K
100%
29 Dec 2025
President, R&D & CMO
Sold on a plan
45,000
$1.83M
100%
17 decisions on file.